BPA for wakix base year with four one year option periods

Ended Awarded Last action

Contract number
36E79720A0013
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 100% complete
IDV ceiling
$5,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Acquisition Center, a civilian agency within the U.S. Department of Veterans Affairs (VA), awarded a $5,000,000 Blanket Purchase Agreement (BPA) to Harmony Biosciences LLC for the procurement of WAKIX (pitolisant) tablets. WAKIX is a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients.

The BPA, awarded under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), has a base year and four one-year option periods, with a total period of performance from June 2020 through June 2025. In addition to the BPA, Harmony Biosciences has received multiple firm-fixed-price delivery orders from the VA Veterans Health Administration against the GSA schedule to supply WAKIX and PITOLISANT, the active ingredient in WAKIX, to VA medical centers nationwide. These delivery orders range in value from $10,000 to over $500,000. Harmony Biosciences also holds a $259,000 multiple award indefinite-delivery indefinite-quantity contract with the VA to provide drugs and pharmaceuticals against the GSA schedule.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 · 2025 public law pricing updates $0
Exercise an Option P00009 · Exercise option year 4 $0
Supplemental Agreement for work within scope P00008 · 2024 public law pricing updates $0
Exercise an Option P00007 · Exercise the 3RD option year on BPA 36E79720A0013 $0
Supplemental Agreement for work within scope P00006 · 2023 public law pricing updates $0
Exercise an Option P00005 · Exercise the second option year BPA 36E79720A0013 $0
Other Administrative Action P00004 · Change in ordering - wakix $0
Supplemental Agreement for work within scope P00003 · 2022 public law pricing updates for wakix tablets. $0
Exercise an Option P00002 · Exercise option year 1 for wakix. $0
Supplemental Agreement for work within scope P00001 · 2021 public law pricing updates $0
Original award $0
Show all 11

Quick answers

Who was awarded contract 36E79720A0013?

36E79720A0013 was awarded to Harmony Biosciences LLC by National Acquisition Center (Headquarters) on June 16, 2020.

How much is contract 36E79720A0013 worth?

36E79720A0013's own ceiling is $5,000,000.

Who can order from contract 36E79720A0013?

36E79720A0013 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79720A0013 under another contract?

Yes. 36E79720A0013 is a blanket purchase agreement under 36F79720D0148, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79720A0013 competed?

The extent of competition for 36E79720A0013 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV